SCHEMBL6000564

SCHEMBL6000564

CN(Cc1ccc(C2CCCCC2)cc1)c1ccc(-c2csc(CN3CCC(C(=O)O)CC3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 6/20 0.42
S1PR5 Q9H228 4/20 0.42
S1PR4 O95977 3/20 0.42
S1PR3 Q99500 2/20 0.42
CTSL P07711 2/20 0.38
CTSB P07858 2/20 0.38
CTSS P25774 2/20 0.38
MRE11 P49959 1/20 0.37
TRPA1 O75762 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
ENPP2 Q13822 1/20 0.36
SIGMAR1 Q99720 1/20 0.35
LTA4H P09960 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
BAZ2A Q9UIF9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5999096 0.91 S1PR1 (0.44) S1PR1S1PR5S1PR4S1PR3LTA4H
SCHEMBL6000648 0.90 ITGB3 (0.42) S1PR1S1PR5S1PR4S1PR3CTSL
SCHEMBL6000915 0.86 CTSL (0.38) CTSLCTSBCTSSMRE11TRPA1
SCHEMBL6001092 0.83 CTSL (0.38) S1PR1S1PR5S1PR4S1PR3CTSL
SCHEMBL6001059 0.83 RXRA (0.42) S1PR1MRE11TRPA1KDM4EALDH1A1
SCHEMBL5999217 0.82 STAT3 (0.39) S1PR1S1PR5S1PR3MRE11TRPA1
SCHEMBL6000571 0.82 S1PR1 (0.42) S1PR1S1PR5S1PR4S1PR3CTSL
SCHEMBL6000602 0.81 STAT3 (0.41) MRE11TRPA1
SCHEMBL6000063 0.80 MRE11 (0.40) S1PR1S1PR5MRE11TRPA1ALDH1A1
SCHEMBL5999733 0.80 RXRA (0.42) S1PR1MRE11TRPA1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 S1PR1 740/4885S1PR5 1297/4885S1PR4 1253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.